Medical genetics: 1. Clinical teratology in the age of genomics
Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogen...
Gespeichert in:
Veröffentlicht in: | Canadian Medical Association journal 2002-08, Vol.167 (3), p.265-273 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 273 |
---|---|
container_issue | 3 |
container_start_page | 265 |
container_title | Canadian Medical Association journal |
container_volume | 167 |
creator | Polifka, Janine E Friedman, J.M |
description | Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_117475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>153561031</sourcerecordid><originalsourceid>FETCH-LOGICAL-h319t-9b36f57d8e33ece628ed19e93dabc1fa5bf8838b60ae4b95d3b8b73de3f2e2813</originalsourceid><addsrcrecordid>eNpVkN1LwzAUxYMobk7_BSk--FbJV9NEEJHhF0x80eeQtLdtRtvMtrPsvzdzU_Tpwrm_c-7lHKAp4VLGlFF1iKYYYxlzjtUEnfT9EuOgY36MJoQSKUiaTNHtC-QuM3VUQguDy_rriFxF89q13-oAnRl87ctN5NpoqCAyJUS-2OK-CfgpOipM3cPZfs7Q-8P92_wpXrw-Ps_vFnHFiBpiZZkokjSXwBhkIKiEnChQLDc2I4VJbCElk1ZgA9yqJGdW2pTlwAoKVBI2Qze73NXaNpBn0A6dqfWqc43pNtobp_9vWlfp0n9qQlKeJsF_sfd3_mMN_aCXft214WUdKlFCcLqFzv8e-U3_qSsAlzugcmU1ug5035i6DjjR4zgSkWqmqUjYFyxsdUo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204966425</pqid></control><display><type>article</type><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Polifka, Janine E ; Friedman, J.M</creator><creatorcontrib>Polifka, Janine E ; Friedman, J.M</creatorcontrib><description>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</description><identifier>ISSN: 0008-4409</identifier><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>PMID: 12186175</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Canada: Can Med Assoc</publisher><subject>Adult ; Alcohol Drinking - adverse effects ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Congenital diseases ; Drugs ; Environmental Exposure ; Epilepsy - drug therapy ; Female ; Genetic Counseling ; Genetic Predisposition to Disease ; Genetic Testing ; Genetics ; Genetics, Medical - trends ; Humans ; Physiological aspects ; Pregnancy ; Review ; Risk Assessment ; Smoking - adverse effects ; Teratogens - toxicity ; Toxic chemicals ; Valproic Acid - adverse effects ; Valproic Acid - therapeutic use</subject><ispartof>Canadian Medical Association journal, 2002-08, Vol.167 (3), p.265-273</ispartof><rights>Copyright Canadian Medical Association Aug 6, 2002</rights><rights>2002 Canadian Medical Association or its licensors</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC117475/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC117475/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12186175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polifka, Janine E</creatorcontrib><creatorcontrib>Friedman, J.M</creatorcontrib><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><title>Canadian Medical Association journal</title><addtitle>CMAJ</addtitle><description>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</description><subject>Adult</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Anticonvulsants - adverse effects</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Congenital diseases</subject><subject>Drugs</subject><subject>Environmental Exposure</subject><subject>Epilepsy - drug therapy</subject><subject>Female</subject><subject>Genetic Counseling</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Testing</subject><subject>Genetics</subject><subject>Genetics, Medical - trends</subject><subject>Humans</subject><subject>Physiological aspects</subject><subject>Pregnancy</subject><subject>Review</subject><subject>Risk Assessment</subject><subject>Smoking - adverse effects</subject><subject>Teratogens - toxicity</subject><subject>Toxic chemicals</subject><subject>Valproic Acid - adverse effects</subject><subject>Valproic Acid - therapeutic use</subject><issn>0008-4409</issn><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpVkN1LwzAUxYMobk7_BSk--FbJV9NEEJHhF0x80eeQtLdtRtvMtrPsvzdzU_Tpwrm_c-7lHKAp4VLGlFF1iKYYYxlzjtUEnfT9EuOgY36MJoQSKUiaTNHtC-QuM3VUQguDy_rriFxF89q13-oAnRl87ctN5NpoqCAyJUS-2OK-CfgpOipM3cPZfs7Q-8P92_wpXrw-Ps_vFnHFiBpiZZkokjSXwBhkIKiEnChQLDc2I4VJbCElk1ZgA9yqJGdW2pTlwAoKVBI2Qze73NXaNpBn0A6dqfWqc43pNtobp_9vWlfp0n9qQlKeJsF_sfd3_mMN_aCXft214WUdKlFCcLqFzv8e-U3_qSsAlzugcmU1ug5035i6DjjR4zgSkWqmqUjYFyxsdUo</recordid><startdate>20020806</startdate><enddate>20020806</enddate><creator>Polifka, Janine E</creator><creator>Friedman, J.M</creator><general>Can Med Assoc</general><general>CMA Impact, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20020806</creationdate><title>Medical genetics: 1. Clinical teratology in the age of genomics</title><author>Polifka, Janine E ; Friedman, J.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h319t-9b36f57d8e33ece628ed19e93dabc1fa5bf8838b60ae4b95d3b8b73de3f2e2813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Anticonvulsants - adverse effects</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Congenital diseases</topic><topic>Drugs</topic><topic>Environmental Exposure</topic><topic>Epilepsy - drug therapy</topic><topic>Female</topic><topic>Genetic Counseling</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Testing</topic><topic>Genetics</topic><topic>Genetics, Medical - trends</topic><topic>Humans</topic><topic>Physiological aspects</topic><topic>Pregnancy</topic><topic>Review</topic><topic>Risk Assessment</topic><topic>Smoking - adverse effects</topic><topic>Teratogens - toxicity</topic><topic>Toxic chemicals</topic><topic>Valproic Acid - adverse effects</topic><topic>Valproic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polifka, Janine E</creatorcontrib><creatorcontrib>Friedman, J.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference & Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polifka, Janine E</au><au>Friedman, J.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical genetics: 1. Clinical teratology in the age of genomics</atitle><jtitle>Canadian Medical Association journal</jtitle><addtitle>CMAJ</addtitle><date>2002-08-06</date><risdate>2002</risdate><volume>167</volume><issue>3</issue><spage>265</spage><epage>273</epage><pages>265-273</pages><issn>0008-4409</issn><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><abstract>Teratogenic exposures are those that can cause an embryo or fetus to develop abnormally. Several factors determine whether an agent is teratogenic, including the gestational timing of the exposure, as well as the dose, route and nature of the agent itself. We review the general concepts of teratogenesis, as well as known genetic susceptibilities to teratogenic effects, with a special focus on antiepileptic drugs. We discuss general principles of risk counselling and risk reduction, and we describe several long-known teratogens, as well as several exposures recognized only recently to have teratogenic potential.</abstract><cop>Canada</cop><pub>Can Med Assoc</pub><pmid>12186175</pmid><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-4409 |
ispartof | Canadian Medical Association journal, 2002-08, Vol.167 (3), p.265-273 |
issn | 0008-4409 0820-3946 1488-2329 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_117475 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adult Alcohol Drinking - adverse effects Anticonvulsants - adverse effects Anticonvulsants - therapeutic use Congenital diseases Drugs Environmental Exposure Epilepsy - drug therapy Female Genetic Counseling Genetic Predisposition to Disease Genetic Testing Genetics Genetics, Medical - trends Humans Physiological aspects Pregnancy Review Risk Assessment Smoking - adverse effects Teratogens - toxicity Toxic chemicals Valproic Acid - adverse effects Valproic Acid - therapeutic use |
title | Medical genetics: 1. Clinical teratology in the age of genomics |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A50%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20genetics:%201.%20Clinical%20teratology%20in%20the%20age%20of%20genomics&rft.jtitle=Canadian%20Medical%20Association%20journal&rft.au=Polifka,%20Janine%20E&rft.date=2002-08-06&rft.volume=167&rft.issue=3&rft.spage=265&rft.epage=273&rft.pages=265-273&rft.issn=0008-4409&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E153561031%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204966425&rft_id=info:pmid/12186175&rfr_iscdi=true |